0000874716-24-000042.txt : 20240216 0000874716-24-000042.hdr.sgml : 20240216 20240216175800 ACCESSION NUMBER: 0000874716-24-000042 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240214 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schreck Michael CENTRAL INDEX KEY: 0002004990 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 24649867 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 wk-form4_1708124258.xml FORM 4 X0508 4 2024-02-14 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0002004990 Schreck Michael ONE IDEXX DRIVE WESTBROOK ME 04092 0 1 0 0 Executive Vice President 0 Common Stock 2024-02-14 4 M 0 80 0 A 615 D Common Stock 2024-02-14 4 M 0 118 0 A 733 D Common Stock 2024-02-14 4 M 0 170 0 A 903 D Common Stock 2024-02-14 4 F 0 117 560.56 D 786 D Non-Qualified Stock Option (right-to-buy) 560.56 2024-02-14 4 A 0 5407 0 A 2034-02-13 Common Stock 5407 5407 D Incentive Stock Option (right-to-buy) 560.56 2024-02-14 4 A 0 178 0 A 2034-02-13 Common Stock 178 178 D Restricted Stock Unit 2024-02-14 4 A 0 1204 0 A Common Stock 1204 1204 D Restricted Stock Unit 2024-02-14 4 M 0 80 0 D Common Stock 80 80 D Restricted Stock Unit 2024-02-14 4 M 0 118 0 D Common Stock 118 234 D Restricted Stock Unit 2024-02-14 4 M 0 170 0 D Common Stock 170 508 D Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2025. Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2028. Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2025. Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four equal annual installments beginning on February 14, 2022. Each RSU represents a contingent right to receive one share of Issuer. common stock and vest in four equal annual installments beginning on February 14, 2023. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four equal annual installments beginning on February 14, 2024. /s/ Lily J. Lu, Attorney-in-Fact for Michael Schreck 2024-02-16